Prostate Cancer Screening Using a Prostate-specific Antigen (PSA) Test or Digital Rectal Exam
Do not routinely screen for prostate cancer using a prostate-specific antigen (PSA) test or digital rectal exam.
- There is convincing evidence that PSA-based screening leads to substantial over-diagnosis of prostate tumors.
- Many tumors will not harm patients, while the risks of treatment are significant.
- Physicians should not offer or order PSA screening unless they are prepared to engage in shared decision making that enables an informed choice by patients.
AAFP Recommendation: http://www.aafp.org/online/en/home/clinical/exam/prostatecancer.html